After eight-year-tolerance minimal i.v. anti-D infusions unleash hemolysis in a patient with immune thrombocytopenic purpura (ITP)

This publication has 16 references indexed in Scilit:

• Fibrosis regression induced by intravenous gammaglobulin treatment
  Annals of the Rheumatic Diseases, 2003
• Methotrexate treatment and mortality in rheumatoid arthritis
  The Lancet, 2002
• Immune pathophysiology of autoimmune thrombocytopenic purpura
  Blood Reviews, 2002
• Renal failure after anti-D globulin treatment of idiopathic thrombocytopenic purpura
  Pediatric Nephrology, 2002
• Intravenous Anti-D Immune Globulin-Induced Intravascular Hemolysis in Epstein–Barr Virus-Related Thrombocytopenia
  Journal of Pediatric Hematology/Oncology, 2001
• Poursuite du traitement d’une polymyositepar les immunoglobulines intraveineuses polyvalentesmalgré la survenue d’une anémie hémolytique sévère
  Transfusion Clinique et Biologique, 2001
• Mechanism of anti-D-mediated immune suppression – a paradox awaiting resolution?
  Trends in Immunology, 2001
• Release of cytokines and soluble cytokine receptors after intravenous anti-D treatment in children with chronic thrombocytopenic purpura
  The Hematology Journal, 2001
• Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rho(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients
  Blood, 2000
• Severe Immune Haemolytic Anaemia Caused by Intravenous Immunoglobulin Anti‐D in the Treatment of Autoimmune Thrombocytopenia
  Vox Sanguinis, 1993